The Oncotype DX (R) Breast test to guide management of node-positive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience

Battisti N. M. L.; Gutteridge E.; Mylvaganam S.; Parton M.; Ring A.; McGrath S. E.

首页> 外文期刊>The Breast : >The Oncotype DX (R) Breast test to guide management of node-positive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience

【24h】

The Oncotype DX (R) Breast test to guide management of node-positive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience

机译：on型DX（R）乳房检测，指导节点阳性雌激素受体阳性HER2阴性乳腺癌患者的管理：英国经验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2019年第2019期|共1页
作者
Battisti N. M. L.; Gutteridge E.; Mylvaganam S.; Parton M.; Ring A.; McGrath S. E.;
展开▼
作者单位

Royal Marsden NHS Fdn Trust Breast Unit Sutton Surrey England;

Nottingham Univ Hosp NHS Trust Nottingham England;

Royal Wolverhampton Hosp NHS Trust Wolverhampton W Midlands England;

Royal Marsden NHS Fdn Trust Breast Unit Sutton Surrey England;

Royal Marsden NHS Fdn Trust Breast Unit Sutton Surrey England;

Royal Marsden NHS Fdn Trust Breast Unit Sutton Surrey England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. The Oncotype DX (R) Breast test to guide management of node-positive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience [J] . Battisti N. M. L., Gutteridge E., Mylvaganam S., The Breast : . 2019,第期

机译：on型DX（R）乳房检测，指导节点阳性雌激素受体阳性HER2阴性乳腺癌患者的管理：英国经验
2. Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come [J] . Mittendorf Elizabeth A., King Tari A. Annals of surgical oncology . 2019,第5期

机译：节点阳性激素受体阳性乳腺癌中的常规使用Oncotype DX复发评分测试：时间已经到来
3. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database [J] . Roberts Megan C., Miller Dave P., Shak Steven, Breast cancer research and treatment. . 2017,第2期

机译：乳腺癌的患者患者患者患者患者患者阳性侵袭性乳腺癌和癌型DX复发得分在SER数据库中产生
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. The Impact of the "American Society of Breast Surgeons 2019 Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer" on Cancer Genetic Counselors [D] . ?Tokarczyk, Jillian 2020

机译：“美国乳房外科医生2019年围攻指南对遗传乳腺癌遗传检测”的影响癌症遗传咨询师
6. Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative lymph node-positive breast cancer [O] . Hee Jeong Kim, Woo Chul Noh, Eun Sook Lee, 2020

机译：新辅助内分泌治疗与新辅助化疗相比在绝经前患有雌激素受体阳性和HER2阴性淋巴结阳性的乳腺癌患者中的疗效
7. Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come [O] . Elizabeth A. Mittendorf, Tari A. King 2019

机译：常规使用在节点阳性激素受体阳性Her2阴性乳腺癌中的Oncotype DX复发评分测试：时间来了

The Oncotype DX (R) Breast test to guide management of node-positive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience

著录项

相似文献

相关主题

期刊订阅